Betabloqueantes en el tratamiento de la insuficiencia cardiaca estable en atención primaria

The majority of adverse events were mild. Treatment was withdrawn in only a few patients and most reached the recommended target dose. Appropriately trained primary care physicians can uptitrate beta-blockers in heart failure patients without undue concern.